Toluene metabolism by cDNA-expressed human hepatic cytochrome P450

Biochemical Pharmacology

Volumn 53, Issue 3, 1997, Pages 271-277

  Nakajima, Tamie ^a   Wang, Rui Sheng ^a   Elovaara, Eivor ^b   Gonzalez, Frank J ^c   Gelboin, Harry V ^c   Raunio, Hannu ^d   Pelkonen, Olavi ^d   Vainio, Harri ^b   Aoyama, Toshifumi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF OULU   (Finland)

Author keywords

human cytochrome P450; human liver microsomes; mouse cytochrome P450; rat cytochrome P450; smoking; toluene metabolism

Indexed keywords

BENZYL ALCOHOL; COMPLEMENTARY DNA; CYTOCHROME P450 ISOENZYME; ORTHO CRESOL; PARA CRESOL; TOLUENE;

AMINO ACID SEQUENCE; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME STRUCTURE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CULTURE; LIVER MICROSOME METABOLISM; MALE; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VACCINIA VIRUS; XENOBIOTIC METABOLISM;

ANIMALS; CELLS, CULTURED; CYTOCHROME P-450 CYP2B1; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; MALE; MICROSOMES, LIVER; RATS; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TOLUENE;

EID: 0031047813     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00652-1     Document Type: Article

References (28)

1. International Agency for Research on Cancer, Toluene. IARC Monogr Eva Carcinog Risks Chem Hum 47: 79-123, 1989.
2. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Goto O, Okuda K and Nebert DW, The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 10: 1-51, 1993.
3. Nakajima T, Wang R-S and Murayama N, Immunochemical assessment of the influence of nutritional, physiological and environmental factors on the metabolism of toluene. Int Arch Occup Environ Health 65: S127-S130, 1993.
4. 5. Biochemistry 22: 4846-4855, 1983.
5. Nise G, Urinary excretion of o-cresol and hippuric acid after toluene exposure in rotogravure printing. Int Arch Occup Environ Health 69: 377-381, 1992.
6. Dossing M, Aelun JB, Hansen SH, Lundqvist GR and Anderssen NT, Urinary hippuric acid and orthocresol excretion in man during experimental exposure to toluene. Br J Ind Med 40: 470-473, 1983.
7. Nakajima T, Wang R-S, Elovaara E, Park SS, Gelboin HV, Hietanen E and Vainio H, Monoclonal antibody-directed characterization of cytochrome P450 isozymes responsible for toluene metabolism in rat liver. Biochem Pharmacol 41: 395-404, 1991.
8. Gonzalez FJ, Aoyama T and Gelboin HV, Expression of mammalian cytochrome P450 using vaccinia virus. Methods Enzymol 206: 85-92, 1991.
9. Nakajima T, Wang R-S, Elovaara E, Park SS, Gelboin HV and Vainio H, A comparative study on the contribution of cytochrome P450 isozymes to metabolism of benzene, toluene and trichloroethylene in rat liver. Biochem Pharmacol 43: 251-257, 1992.
10. Aoyama T, Gonzalez FJ and Gelboin HV, Human cDNA-expressed cytochrome P450 IA2: Mutagen activation and substrate specificity. Mol Carcinog 2: 192-198, 1989.
11. Yamano S, Tatsuno J and Gonzalez FJ, The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry 29: 1322-1329, 1990.
12. Yamano S, Nhamburo PT, Aoyama T, Meyer UA, Inaba T, Kalow W, Gelboin HV, McBride OW and Gonzalez FJ, cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: Identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver. Biochemistry 28: 7340-7348, 1989.
13. Relling MV, Aoyama T, Gonzalez FJ and Meyer UA, Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily. J Pharmacol Exp Ther 252: 442-447, 1990.
14. Aoyama T, Gelboin HV and Gonzalez FJ, Mutagenic activation of 2-amino-3-methylimidazo [4,5-f]quinoline by complementary DNA-expressed human liver P-450. Cancer Res 50: 2060-2063, 1990.
15. 1. Proc Natl Acad Sci USA 87: 4790-4793, 1990.
16. Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV and Gonzalez FJ, Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. J Biol Chem 264: 10388-10395, 1989.
17. Aoyama T, Gonzalez FJ and Gelboin HV, Mutagen activation by c-DNA-expressed P(1)450, P(3)450, and P450a. Mol Carcinog 1: 253-259, 1989.
18. 5 potentiation of cytochrome P-450 catalytic activity demonstrated by a vaccinia virus-mediated in situ reconstitution system. Proc Natl Acad Sci USA 87: 5425-5429, 1990.
19. Aoyama T, Korzekwa K, Nagata K, Adesnik M, Reiss A, Lapenson DP, Gillette J, Gelboin HV, Waxman DJ and Gonzalez FJ, Sequence requirement for cytochrome P450 IIB1 catalytic activity: Alteration of the stereospecificity and regioselectivity of steroid hydroxylation by a simultaneous change of two hydrophohic amino acid residues to phenylalanine. J Biol Chem 264: 21327-21333, 1989.
20. Nakajima T, Elovaara E, Gonzalez FJ, Gelboin HV, Raunio H, Pelkonen O, Vainio H and Aoyama T, Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochrome P450. Chem Res Toxicol 7: 891-896, 1994.
21. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ, Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
22. Omura T and Sato R, The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239: 2370-2378, 1964.
23. Wang R-S and Nakajima T, Effects of ethanol and phenobarbital treatments on the pharmacokinetics of toluene in rats. Br J Ind Med 49: 104-112, 1992.
24. Wang R-S and Nakajima T, Kinetic studies on toluene metabolism in ethanol- and phenobarbital-induced rat liver microsomes in vitro. Arch Toxicol 65: 39-44, 1991.
25. Duthie SJ, Coleman CS and Grant MH, Status of reduced glutathione in the human hepatoma cell line, HEP G2. Biochem Pharmacol 37: 3365-3368, 1988.
26. Lyu PC, Liff MI, Marky LA and Kallenbach NR, Side chain contributions to the stability of alpha-helical structure in peptides. Science 250: 669-673, 1990.
27. O'Neil KT and DeGrado WF, A thermodynamic scale for the helix-forming tendencies of the commonly occurring amino acids. Science 250: 646-651, 1990.
28. Christou M, Mitchell MJ, Aoyama T, Gelboin HV, Gonzalez FJ and Jefcoate CR, Selective suppression of the catalytic activity of cDNA-expressed cytochrome P4502B1 toward polycyclic hydrocarbons in the microsomal membrane: Modification of this effect by specific amino acid substitutions. Biochemistry 31: 2835-2841, 1992.